FDA 483 - Jubilant DraxImage Radiopharmacies Inc. dba Jubilant Radiopharma - March 13, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
This FDA Form 483 documents observations from an inspection of Jubilant Draximage Radiopharmacies Inc. dba Jubilant Radiopharma, a nuclear pharmacy located at 4205 Vineland Rd Ste L13, Orlando, FL 32811-6601. The inspection was conducted from March 5, 2024, to March 13, 2024, and the report was issued to Dr. Larry E. Jones Jr., Pharmacy Manager.
The inspection revealed six observations:
1. **Aseptic Processing Outside ISO 5 Area:** On March 6, 2024, during Gozetotide (Illucix) Cold Kit Lot# K-20240306-069 production, the Pharmacy Manager performed aseptic connections (connecting sterile (b)(4) to the Gallium Generator and sterile (b)(4) to the Gallium Generator) in the ISO-7 aseptic processing area, not the required ISO 5 area. 2. **Blocked "First Air" in ISO 5 Area:** On March 6, 2024, during the same Gozetotide production, the Pharmacy Manager was observed blocking first pass air in the ISO-5 (b)(4) flow hood. 3. **Use of Non-Sterile Disinfecting Agents and Cleaning Pads:** The firm uses
- Inspection Date
- March 13, 2024
- Product Type
- Drugs
ID · 050bbbef-54ff-4db7-9d28-27196dc2c126
Full citation text and observation details available on the Dashboard.